The weekly litigation news digest is live. Subscribe now

IP Verse

Mesenchymal Stem Cells And Uses Therefor - EP2298862

The patent EP2298862 was granted to Mesoblast on Aug 30, 2017. The application was filed on Mar 15, 2005 under application number EP10011224A. The patent is currently recorded with a legal status of "Opposition Rejected".

EP2298862

MESOBLAST
Application Number
EP10011224A
Filing Date
Mar 15, 2005
Status
Opposition Rejected
Feb 14, 2020
Publication Date
Aug 30, 2017
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
FRIEDRICHMay 30, 2018BREUER FRIEDRICH HAHNER PATENTANWALTE PARTG MBBADMISSIBLE

Patent Citations (11) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS5486359
DESCRIPTIONUS6355239
OPPOSITIONWO2008042174
OPPOSITIONWO9951247
OPPOSITIONWO9951275
SEARCHCN1536075
SEARCHWO03004661
SEARCHWO03059276
SEARCHWO2004006942
SEARCHWO2004011621
SEARCHWO2004084950

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents